La commission d'hemovigilance du CHU. ; The Hemovigilance Commission of the University Hospital Center
peer reviewed ; As suggested by the National Blood Council, a Hemovigilance Committee was set up in the University Hospital of Liege in 1995. A multidisciplinary discussion takes place on any action aiming at the improvement of transfusion safety, and the follow-up of its implementation. The first issue to be discussed was the set up of a detailed documentation of all blood transfusions. The data are now recorded on a single document allowing proper identification of people and products involved, and of the eventual incidents. This document has lead to a better transfusion safety and to an imp... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | journal article |
Erscheinungsdatum: | 2000 |
Verlag/Hrsg.: |
Hopital de Baviere
|
Schlagwörter: | Belgium / Blood / Blood Banks/standards / Blood Donors / Blood Grouping and Crossmatching / Blood Transfusion/adverse effects/standards / Blood Transfusion / Autologous / Documentation / Follow-Up Studies / Hospitals / University / Humans / Incidence / Risk Management / Safety / Human health sciences / Sciences de la santé humaine |
Sprache: | Französisch |
Permalink: | https://search.fid-benelux.de/Record/base-28535094 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://orbi.uliege.be/handle/2268/7557 |
peer reviewed ; As suggested by the National Blood Council, a Hemovigilance Committee was set up in the University Hospital of Liege in 1995. A multidisciplinary discussion takes place on any action aiming at the improvement of transfusion safety, and the follow-up of its implementation. The first issue to be discussed was the set up of a detailed documentation of all blood transfusions. The data are now recorded on a single document allowing proper identification of people and products involved, and of the eventual incidents. This document has lead to a better transfusion safety and to an improved administrative management of blood transfusion. The Commission has been coordinating two multi-centric studies analyzing the consumption of fresh blood products and the incidence of transfusion reactions. Among blood-saving policies, autologous transfusion and volume reduction of samples drawn for laboratory purposes have been discussed. Other measures were taken to improve the labeling of samples for cross-mach and to actively follow-up transfusion reactions. By its actions and advises, the Commission aims to direct strategies towards a safe and rational use of blood products.